NRBO News
Archived Headlines
- US IPO Weekly Recap: Post-holiday week sees temporary IPO lull 07/08/16
- US IPO Week Ahead: Two delayed health care IPOs 07/01/16
- US IPO Week Ahead: Two biotechs, one device maker and one health care REIT 06/24/16
- US IPO Week Ahead: IPO market discovers whether unicorns can fly with tech firm Twilio 06/17/16
- High cholesterol? Gemphire Therapeutics sets terms for $45 million IPO 06/13/16
See more
US IPO Weekly Recap: 4 IPOs price as Hawaii's top bank gains 8%
Four IPOs raised almost $700 million this past week. Coming in first was First Hawaiian with an 8% gain; the state's largest bank raised $485 million in the largest banking IPO since 2014. Meanwhile, high-growth retailer At Home Group was not a home run, trading...read more
Lower cholesterol: Gemphire Therapeutics prices IPO at $10, below the range
Gemphire Therapeutics, which is developing a novel nonstatin therapy to treat high cholesterol, raised $30 million by offering 3 million shares at $10, below the range of $11 to $13. Gemphire Therapeutics plans to list on the Nasdaq under the symbol GEMP....read more
Cholesterol lowered: Gemphire Therapeutics decreases IPO deal size to $30 million
Gemphire Therapeutics, which is developing a novel nonstatin therapy to treat high cholesterol, lowered the proposed deal size for its upcoming IPO on Thursday. The Northville, MI-based company now plans to raise $30 million by offering 3.0 million shares...read more
US IPO Week Ahead: Three profitable IPOs and a biotech look to raise $900 million
Four IPOs are on the calendar to raise nearly $900 million in the week ahead. Three are profitable, including the fourth-largest offering of 2016 and two companies that...read more